OAS1 抗体 (C-Term)
-
- 抗原 See all OAS1 抗体
- OAS1 (2',5'-Oligoadenylate Synthetase 1, 40/46kDa (OAS1))
-
抗原表位
- C-Term
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This OAS1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- OAS1 antibody was raised against the C terminal of OAS1
- 纯化方法
- Affinity purified
- 免疫原
- OAS1 antibody was raised using the C terminal of OAS1 corresponding to a region with amino acids GWRQLAQEAEAWLNYPCFKNWDGSPVSSWILLVRPPASSLPFIPAPLHEA
- Top Product
- Discover our top product OAS1 Primary Antibody
-
-
- 应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
OAS1 Blocking Peptide, catalog no. 33R-3670, is also available for use as a blocking control in assays to test for specificity of this OAS1 antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of OAS1 antibody in PBS
- 浓度
- Lot specific
- 缓冲液
- PBS
- 注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- 抗原
- OAS1 (2',5'-Oligoadenylate Synthetase 1, 40/46kDa (OAS1))
- 别名
- OAS1 (OAS1 产品)
- 别名
- OAS1 antibody, IFI-4 antibody, OIAS antibody, OIASI antibody, L3 antibody, Pp2a2 antibody, 2',5'-oligoadenylate synthetase 1 antibody, 2'-5'-oligoadenylate synthetase 1 antibody, 2'-5' oligoadenylate synthetase 1A antibody, protein phosphatase 2 catalytic subunit beta antibody, OAS1 antibody, Oas1a antibody, Ppp2cb antibody, Oas1 antibody
- 背景
- OAS1 is a member of the 2-5A synthetase family, essential proteins involved in the innate immune response to viral infection. It is induced by interferons and uses adenosine triphosphate in 2'-specific nucleotidyl transfer reactions to synthesize 2',5'-oligoadenylates (2-5As). These molecules activate latent RNase L, which results in viral RNA degradation and the inhibition of viral replication. Mutations in this gene have been associated with host susceptibility to viral infection.
- 分子量
- 42 kDa (MW of target protein)
- 途径
- Hepatitis C
-